CNBX Pharmaceuticals Inc. filed its 10-K on Nov 30, 2022 for the period ending Aug 31, 2022. In this report its auditor, Weinstein International CPA, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0075 USD | -1.32% |
|
-5.06% | -47.18% |
1st Jan change | Capi. | |
---|---|---|
-47.18% | 233K | |
+16.44% | 122B | |
+18.94% | 113B | |
+18.84% | 26.22B | |
-25.37% | 19.01B | |
-19.77% | 15.71B | |
-20.20% | 15.22B | |
-47.37% | 14.72B | |
+59.91% | 14.58B | |
+4.35% | 13.84B |
- Stock Market
- Equities
- CNBX Stock
- News CNBX Pharmaceuticals Inc.
- CNBX Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt